For the Inventor, By the Inventor

Enter assignee name

Sekisui Medical Co., Ltd.

USPTO Granted Patents = 150

CIPO Patents = 12

EPO Patents = 137

Trademarks = 7

Forward Citations = 351

Loading Chart...

Loading Chart...

208 inventors (with patents filed for the assignee):

Takuya Yotani (23 out of 23 patents)

Mitsuaki Yamamoto (17 out of 20 patents)

Motoki Morita (13 out of 40 patents)

4. Keigo Kohno (13 out of 13 patents)

5. Hiroaki Taira (12 out of 12 patents)

6. Hiroyuki Ebinuma (12 out of 23 patents)

7. Ryusuke Okamoto (11 out of 19 patents)

8. Takayuki Oka (10 out of 10 patents)

9. Masato Nishikawa (10 out of 11 patents)

10. Tomo Shimizu (9 out of 9 patents)

11. Shinya Yano (8 out of 24 patents)

12. Mayumi Yoshida (8 out of 15 patents)

13. Shinya Yokokawa (8 out of 8 patents)

14. Hideki Muraki (7 out of 7 patents)

15. Yuki Takahashi (6 out of 248 patents)

Core Competencies:

Immunoassay

Optical Measurement

Blood Coagulation

Nucleic Acid Isolation

Tumor Determination

Serum Separation

Hemoglobin Analysis

Latex Agglutination

Gene Mutation Detection

Automated Analysis

Immunochromatographic Test

Circulating Tumor Cells

150 patents: Sort by Forward Citations

1. 12504434 - Method for measuring blood coagulation time (2025-12-23),

2. 12390563 - Clot adhesion preventing agent and blood collection container (2025-08-19),

3. 12352766 - Immunoassay method for free aim in biological sample, and method for detecting NASH in subject (2025-07-08),

4. 12345705 - Immunochromatographic test strip and immunochromatographic detection kit (2025-07-01),

5. 12345628 - Optical measurement device and optical measurement method (2025-07-01),

6. 12331092 - Leucine-rich ALPHA2 glycoprotein composition (2025-06-17),

7. 12313638 - Method for analyzing blood coagulation characteristics of blood specimen (2025-05-27),

8. 12270823 - Automated analysis device (2025-04-08),

9. 12265083 - Immunoassay method for free AIM in biological sample, and assay kit (2025-04-01),

10. 12264311 - Method for isolating nucleic acid, nucleic acid isolation kit, and inspection chip (2025-04-01),

11. 12222351 - Immunoassay and measurement reagent for leucine-rich alpha2 glycoprotein (2025-02-11),

12. 12203945 - Haemoglobin analysis method for detecting abnormal haemoglobins and/or thalassemia markers (2025-01-21),

13. 12174204 - Analysis method, analysis apparatus, and analysis program (2024-12-24),

14. 12136097 - Genuine product automatic authentication method (2024-11-05),

15. 11993806 - Method of detecting or method of quantifying oligonucleotides (2024-05-28),

SEKISUI MEDICAL CO., LTD. is a leading global medical device manufacturer headquartered in Tokyo, Japan. With a focus on innovation and quality, the company develops and produces a wide range of medical products and equipment for various medical specialties. They offer solutions in the fields of diagnostic systems, surgery and orthopedics, infection control, urology, respiratory care, and more. SEKISUI MEDICAL is committed to advancing healthcare through their cutting-edge technologies and improving patient outcomes worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

150 Patents

#372 in Tokyo

#831 in Japan

#5,310 in the World

Sekisui Medical Co., Ltd.

Forward Citations = 351

208 inventors:

Takuya Yotani (23 out of 23 patents)

Mitsuaki Yamamoto (17 out of 20 patents)

Motoki Morita (13 out of 40 patents)

4. Keigo Kohno (13 out of 13 patents)

5. Hiroaki Taira (12 out of 12 patents)

Please report any incorrect information to support@idiyas.com

Loading…